Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/20/2013DE202010018076U1 Zusammensetzung und deren Verwendung zum Verzögern und Verbessern einer photoinduzierten Netzhautschädigung und von Katarakten unter Verbesserung eines Xerophthalmiesyndroms Composition and its use for delaying and improving a photo-induced retinal damage and cataracts, enhancing a Xerophthalmiesyndroms
11/20/2013CN103403553A Modulators for SIRT6 and assays for screening same
11/20/2013CN103403017A Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
11/20/2013CN103403014A O-(replaced benzyl)phosphoramidate and use thereof
11/20/2013CN103403013A Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
11/20/2013CN103403010A Inhibitors of polo-like kinase
11/20/2013CN103403009A Macrocyclic inhibitors of flaviviridae viruses
11/20/2013CN103403008A Preparation method of intermediate of sitagliptin
11/20/2013CN103403007A 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
11/20/2013CN103403006A 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
11/20/2013CN103403005A 5-([1,2,3]triazole-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
11/20/2013CN103403004A Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
11/20/2013CN103403003A Bridged piperidine derivatives
11/20/2013CN103403002A Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
11/20/2013CN103403001A Novel heterocyclic derivatives and their use in the treatment of neurological disorders
11/20/2013CN103403000A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
11/20/2013CN103402999A Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
11/20/2013CN103402998A Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
11/20/2013CN103402997A Diaminopyrimidine derivatives and processes for the preparation thereof
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402995A Novel indole or indazole derivative or salt thereof
11/20/2013CN103402994A Heteroaryl derivatives as alpha7 NACHR modulators
11/20/2013CN103402993A Novel esters of 4,9-dihydroxy-naphtho[2,3-b]furans for disease therapies
11/20/2013CN103402989A Tetrazole compounds and methods of making and using same
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402986A Modulators of S1P receptors
11/20/2013CN103402984A Novel kinase inhibitors
11/20/2013CN103402983A (Pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 NACHR
11/20/2013CN103402980A Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines
11/20/2013CN103402977A Ingenol-3-acylates III and ingenol-3-carbamates
11/20/2013CN103402973A Compound and method for producing same, as well as method for producing oseltamivir phosphate
11/20/2013CN103402971A Nicotinic receptor non-competitive antagonists
11/20/2013CN103402969A 3-acyl-ingenols II
11/20/2013CN103402963A Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds
11/20/2013CN103402582A Methods of treating macular edema using anti-edema therapeutics
11/20/2013CN103402543A Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
11/20/2013CN103402536A Methods for treating metabolic disorders and obesity with GIP and GLP-1 receptor-active glucagon-based peptides
11/20/2013CN103402532A Enteral nutrient
11/20/2013CN103402530A Compositions and methods for treating erectile dysfunction
11/20/2013CN103402527A Compositions and methods for cell transplantation
11/20/2013CN103402526A Histone inhibition
11/20/2013CN103402525A Methods of inhibition of protein fucosylation in vivo using fucose analogs
11/20/2013CN103402524A Concomitant drug for improving cognitive function
11/20/2013CN103402523A Steroid tetrol solid state forms-2
11/20/2013CN103402522A Use of N-(4-methoxyphenyl)-1-phenyl-1H-pyrazol-3-amine and related compounds
11/20/2013CN103402521A Methods of treatment using selective BCL-2 inhibitors
11/20/2013CN103402520A Substituted imidazoquinoline derivatives
11/20/2013CN103402519A Therapeutic agent for tumor
11/20/2013CN103402518A Compositions comprising a PI3K inhibitor and a MEK inhibitor and their use for treating cancer
11/20/2013CN103402517A Method of treatment with BRAF inhibitor
11/20/2013CN103402516A Compounds useful as antiviral agents, compositions, and methods of use
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103402514A Combinations of serotonin receptor agonists for treatment of movement disorders
11/20/2013CN103402513A Composition for prevention of nausea or vomiting
11/20/2013CN103402512A Colonoscopy - preparation
11/20/2013CN103402511A Novel benzodioxole piperidine compounds
11/20/2013CN103402510A Composition for the treatment of skin conditions
11/20/2013CN103402509A Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same
11/20/2013CN103402508A Dosages of arylsulfonamide derivatives
11/20/2013CN103402507A Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
11/20/2013CN103402506A Combination for treatment of diabetes mellitus
11/20/2013CN103402505A Dual inhibitors of MET and VEGF for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases
11/20/2013CN103402504A Sildenafil-free base-containing film preparation and method for producing same
11/20/2013CN103402502A Filmcoated solid dosage forms comprising honey in the coating
11/20/2013CN103402501A Modified release benzimidazole formulations
11/20/2013CN103402500A Orally disintegrating tablet
11/20/2013CN103402499A Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
11/20/2013CN103402498A Drug delivery systems
11/20/2013CN103402495A Implant comprising a core and a tube encasing the core
11/20/2013CN103402491A Improved powderous vitamin e formulations
11/20/2013CN103402376A Human milk oligosaccharides to promote growth of beneficial bacteria
11/20/2013CN103402359A Olefin containing nuclear transport modulators and uses thereof
11/20/2013CN103402358A Chemosensory receptor ligand-based therapies
11/20/2013CN103396557A Multifunctional cationic polymer gene vector, and preparation method and application thereof
11/20/2013CN103396521A Synthesis and micellization application of amphiphilic beta-cyclodextrin star polymer
11/20/2013CN103396470A Withanolides type compounds and antitumor use thereof
11/20/2013CN103396462A Curcumin glucoside and preparation method and application thereof in treating Parkinson disease
11/20/2013CN103396453A Pharmaceutical use of Pradefovir
11/20/2013CN103396452A Riboflavin sodium phosphate compound and composition thereof
11/20/2013CN103396437A Bi(tricyclohexyl tin) dicarboxylic ester and preparation method and application thereof
11/20/2013CN103396436A Monobutyltin trichloride substituted salicylidenedimine Schiff base complex as well as preparation method and applications thereof
11/20/2013CN103396435A Dibutyl tin aromatic aldehyde condensed arylamine Schiff base complex as well as preparation method and application thereof
11/20/2013CN103396426A Chiral boric acid derivative as well as preparation method and application thereof
11/20/2013CN103396417A Novel hydroxamic acid derivative and medical application thereof
11/20/2013CN103396415A Novel substituted imidazoquinolines
11/20/2013CN103396414A Imidazolyl-substituted thiazocyclohexane compounds and antitumor application thereof
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/20/2013CN103396405A Benzimidazole-4-formamide derivate with PARP (poly-ADP-ribose polymerase) inhibiting effect
11/20/2013CN103396399A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising same
11/20/2013CN103396398A Prokineticin 1 receptor antagonists
11/20/2013CN103396397A Lenalidomide derivative and use thereof as medicine
11/20/2013CN103396389A Naphthoquinone sesquiterpenes compound and application thereof in preparation of anti-tumour or antibacterial medicine
11/20/2013CN103396386A Di-substituted dinaphtho-[2,1-b:1',2'-d] furan derivative as well as preparation method and application thereof
11/20/2013CN103396378A Stable febuxostat crystal
11/20/2013CN103396361A 3, 4-dihydroisoquinoline antitumor compounds as well as preparation method and application thereof
11/20/2013CN103396351A Pyrrolidone Bc1-2 protein small-molecule inhibitor compound, and preparation, pharmaceutical composition and pharmaceutical use thereof
11/20/2013CN103396348A Rorifone derivatives and applications to preparing anticancer medicaments
11/20/2013CN103396328A Meclofenoxate hydrochloride compound and pharmaceutical composition thereof
11/20/2013CN103396302A Alpha-cyperone and preparation method of preparation thereof
1 ... 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 ... 7860